Page 296 - Syndipharma

Type Product Dosage Form Strength Indication Status

Psudoephedrine/ Chlor- Syrup (10 /0.67) mg/5 ml Decongestant, Antihistamine In market
pheniramine Maleate

Bromhexine Syrup 4 mg/ 5 ml Mucolytic In market

Acetaminophen/Diphen- (160/12.5/2.5) Antipyretic, Antihistamine, Al-
hydramine HCl/ Phenyl- Syrup mg/5 ml pha 1 Agonist (Decongestant) In market
ephrine HCl
Cough Suppres- Acetaminophen/Chlor- Antipyretic, Antihistamine,
sants pheniramine/ Dex- Syrup (160/1/5/2.5) Antitussive, Alpha 1 Agonist In market IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
(analgesics,an- tromethorphan HBr/ mg/5 ml (Decongestant)
tihistamines, Phenylephrine HCl
decongestant
and expecto- Acetaminophen/Guaifen- Syrup (125/50/2.5) mg/5 Antipyretic, expectorant, Al- In market
rants) esin/ Phenylephrine ml pha 1 agonist (Decongestant)

Expectorant (codeine (10,100,30)mg / Antitussive, Expectorant,
phosphate/Guaifenesin/ Syrup 5 ml Decongestant In market
Pseudoephedrine Hcl)
Expectorant (Guaifen-
esin/
Pseudoephedrine Hydro- Syrup (100/30/2) mg/ Expectorant, Decongestant, In market
chloride/ 5 ml Antihistamine
Chloropheniramine
maleate)

Omeprazole capsule 20 mg Proton pump inhibitor In market

Ranitidine Tablet 150,300 mg Histamine (H2) Antagonist In market

Pantoprazole EC Tablet 40 mg Proton pump inhibitor Coming soon

Lactulose Syrup 10 g/ 15 mL Laxative In market
Gastrointestinal
Drugs
Dimeticone Oral drop 40 mg/ml Gastrointestinal agent In market

Metoclopramide Oral drop 4mg/ml Antiemetic In market

Diphenoxylate Tablet 2.5 mg Antidiarrheal In market

Dicyclomine syrup 10mg/5ml Anticholinergic In market

Local Anesthe- Lidocaine Topical spray 10 mg/dose(20, Local anesthetic In market
sia 50,100 ml)
Neuromuscu-
lar Disorders
Multiple Fampridine Tablet 10 mg Multiple sclerosis treatment In market
(multiple scle-
rosis)

Phosphodiesterase- 5 enzyme
Sildenafil Tablet 100 mg In market
inhibitor
Urologic Drugs
Tamsulosin Hydrochlo- Capsule 0.4 mg Alpha 1 blocker In market
ride 295